Tatva Chintan Pharma Chem Ltd
BSE:543321
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tatva Chintan Pharma Chem Ltd
BSE:543321
|
IN |
|
V
|
Vergnet Vsa SA
F:VRQ
|
FR |
|
D
|
Dah Sing Financial Holdings Ltd
F:DSR
|
HK |
|
A
|
Abitibi Metals Corp
OTC:AMQFF
|
CA |
|
Barloworld Ltd
OTC:BRRAF
|
ZA |
|
Mynaric AG
F:M0YN
|
DE |
|
Performance Shipping Inc
F:DS2
|
GR |
|
A
|
ACE Aviation Holdings Inc
XMUN:ACV
|
CA |
|
Pareto Bank ASA
F:8PB
|
NO |
Wall St Price Targets
TATVA Price Targets Summary
Tatva Chintan Pharma Chem Ltd
According to Wall Street analysts, the average 1-year price target for TATVA is 1 467.71 INR with a low forecast of 841.27 INR and a high forecast of 2 047.68 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TATVA's stock price target?
Price Target
1 467.71
INR
According to Wall Street analysts, the average 1-year price target for TATVA is 1 467.71 INR with a low forecast of 841.27 INR and a high forecast of 2 047.68 INR.
What is the Revenue forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
26%
Over the last 6 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 26%.
What is the Gross Profit forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
26%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 2 years is 26%.
What is the Operating Income forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
52%
Over the last 6 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 2 years is 52%.
What is the Pre-Tax Income forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
44%
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 2 years is 44%.
What is the Net Income forecast for Tatva Chintan Pharma Chem Ltd?
Projected CAGR
46%
Over the last 6 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 2 years is 46%.
